Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Research Articles

Catheter-Directed Thrombolysis in Submassive Pulmonary Embolism: Safety and Efficacy
Original Research
Catheter-Directed Thrombolysis in Submassive Pulmonary Embolism: Safety and Efficacy
03/09/2020
Golamari et al assessed the applicability of catheter-directed thrombolysis in submassive pulmonary embolism in a community hospital setting. 
Golamari et al assessed the applicability of catheter-directed thrombolysis in submassive pulmonary embolism in a community hospital setting. 
Golamari et al assessed the...
03/09/2020
Vascular Disease Management
Original Research
Endovascular Repair of Aorto-Enteric Fistulae as a Definitive Treatment Strategy
03/06/2020
Primary AEF is a communication between the aorta and the GI tract due to one of a long list of diseases, while secondary AEF is created after the erosion of an aortic prosthetic graft into the surrounding GI structures.
Primary AEF is a communication between the aorta and the GI tract due to one of a long list of diseases, while secondary AEF is created after the erosion of an aortic prosthetic graft into the surrounding GI structures.
Primary AEF is a communication...
03/06/2020
Vascular Disease Management
Original Research
Effect of Home-Based Exercise Training on Plasma Vascular Endothelial Growth Factor and Ankle-Brachial Index in Patients With Mild Peripheral Artery Disease: A Pilot Study
12/03/2019
Nurgroho and colleagues describe how home-based exercise training improved VEGF level and ABI in patients with PAD.
Nurgroho and colleagues describe how home-based exercise training improved VEGF level and ABI in patients with PAD.
Nurgroho and colleagues describe...
12/03/2019
Vascular Disease Management
Original Research
Acoustic Pulse Thrombolysis Treatment Strategies for Acute Limb Ischemia: An Observational Single-Center Study
11/04/2019
Estes and colleagues report a single-center observational experience in patients presenting with acute limb ischemia and undergoing APT.
Estes and colleagues report a single-center observational experience in patients presenting with acute limb ischemia and undergoing APT.
Estes and colleagues report a...
11/04/2019
Vascular Disease Management
Original Research
Left Atrial Appendage Occlusion as Adjunctive Therapy to Anticoagulation for Stroke Recurrence
05/15/2019
Left atrial appendage occlusion (LAAO) is currently accepted in patients with non-valvular atrial fibrillation (NVAF) and a formal contraindication to oral anticoagulation (OAC) but it might also be considered for those at high risk of...
Left atrial appendage occlusion (LAAO) is currently accepted in patients with non-valvular atrial fibrillation (NVAF) and a formal contraindication to oral anticoagulation (OAC) but it might also be considered for those at high risk of...
Left atrial appendage occlusion...
05/15/2019
Vascular Disease Management
Original Research
Percutaneous Left Atrial Appendage Closure in Patients With Inferior Vena Cava Filters: A Case Series
05/15/2019
The number of percutaneous cardiac interventions for structural heart diseases is increasing, and these interventions concern a growing population. Among these procedures, left atrial appendage (LAA) closure is recommended by the European...
The number of percutaneous cardiac interventions for structural heart diseases is increasing, and these interventions concern a growing population. Among these procedures, left atrial appendage (LAA) closure is recommended by the European...
The number of percutaneous...
05/15/2019
Vascular Disease Management
Original Research
Single Access Versus Dual Antegrade and Retrograde Access Approach for Chronic Total Occlusion Recanalization in Complex Peripheral Arterial Disease
02/22/2019
In this study, researchers evaluated the efficacy and safety of initial dual antegrade and retrograde access approach compared with single antegrade or retrograde approach for crossing any level of CTO.
In this study, researchers evaluated the efficacy and safety of initial dual antegrade and retrograde access approach compared with single antegrade or retrograde approach for crossing any level of CTO.
In this study, researchers...
02/22/2019
Vascular Disease Management
Original Research
Single Access Versus Dual Antegrade and Retrograde Access Approach for Chronic Total Occlusion Recanalization in Complex Peripheral Arterial Disease
02/22/2019
In this study, researchers evaluated the efficacy and safety of initial dual antegrade and retrograde access approach compared with single antegrade or retrograde approach for crossing any level of CTO.
In this study, researchers evaluated the efficacy and safety of initial dual antegrade and retrograde access approach compared with single antegrade or retrograde approach for crossing any level of CTO.
In this study, researchers...
02/22/2019
Vascular Disease Management
Original Research
A Multi-Center, Prospective, Post-Market Registry to Evaluate Procedural Outcomes Using the Cardiva Medical VASCADE Vascular Closure System (VCS)
09/13/2018
A study led by Craig Walker, MD, confirms the safety and efficacy of the VASCADE VCS device when used in closure of antegrade femoral access sites during peripheral endovascular interventions in the treatment of PAD.
A study led by Craig Walker, MD, confirms the safety and efficacy of the VASCADE VCS device when used in closure of antegrade femoral access sites during peripheral endovascular interventions in the treatment of PAD.
A study led by Craig Walker, MD,...
09/13/2018
Vascular Disease Management
Original Research
Facilitated Intraluminal Guidewire Passage in Femoropopliteal Occlusive Pathology: Simplified Instrumentation Technique
07/16/2018
It is estimated that CTO is present in up to 40% of patients with symptomatic PAD. Initial guidewire passage required to perform successful intervention on the atherosclerotic segment becomes more difficult with the occurrence of CTO.
It is estimated that CTO is present in up to 40% of patients with symptomatic PAD. Initial guidewire passage required to perform successful intervention on the atherosclerotic segment becomes more difficult with the occurrence of CTO.
It is estimated that CTO is...
07/16/2018
Vascular Disease Management

Advertisement

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement